MiNK Therapeutics Reports Corporate Update and First Quarter 2023 Financial Results

May 11, 2023

https://www.globenewswire.com/news-release/2023/05/11/2666692/0/en/MiNK-Therapeutics-Reports-Corporate-Update-and-First-Quarter-2023-Financial-Results.html

NEW YORK, May 11, 2023 (GLOBE NEWSWIRE) — MiNK Therapeutics, Inc. (NASDAQ:INKT), a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases, today provided a corporate update and reported financial results for the first quarter 2023.

Read more at globenewswire.com

Related news for (INKT)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.